Live feed
Filing
SC 13G
SC 13G0000935836-21-000462·Aligos Therapeutics, Inc.
Schedule 13G ownership disclosure
ALIGOS THERAPEUTICS INC
Security class unavailable · CUSIP: 01626L105
Event date: 2021-08-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,872,785
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000462
- Form type
- SC 13G
- Filer
- Aligos Therapeutics, Inc.
- CIK
- CIK 1799448
- Filed
- Aug 13, 2021
- Reporting period
- Aug 03, 2021
- Description
- Schedule 13G beneficial ownership